HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 166 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,662,827 | +16.1% | 46,100 | +22.9% | 0.18% | +1.1% |
| Q1 2023 | $1,432,125 | +231.2% | 37,500 | +393.4% | 0.18% | +181.0% |
| Q4 2022 | $432,440 | -32.1% | 7,600 | -52.8% | 0.06% | -51.2% |
| Q3 2022 | $637,000 | -27.3% | 16,100 | -19.1% | 0.13% | -20.9% |
| Q2 2022 | $876,000 | +147.5% | 19,900 | +155.1% | 0.16% | +77.2% |
| Q2 2021 | $354,000 | +0.3% | 7,800 | -7.9% | 0.09% | +13.6% |
| Q1 2021 | $353,000 | -23.6% | 8,465 | -62.9% | 0.08% | -13.8% |
| Q4 2017 | $462,000 | +376.3% | 22,800 | +103.6% | 0.09% | +62.1% |
| Q2 2016 | $97,000 | – | 11,200 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |